The platelet P2 receptors

Platelets, Second Edition

Volumn , Issue , 2006, Pages 201-220

  Cattaneo, Marco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646254999     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369367-9/50772-2     Document Type: Chapter

References (210)

1. P. Abbracchio, M. Boeynaems, A. Barnard, L. Boyer and C. Kennedy (2003) Characterization of the UDPglucose receptor (re-named the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24 52-55.
2. J.M. Boeynaems, D. Communi, G.N. Suarez Gonzales N. and B. Robaye (2005) Overview of the P2 receptors. Semin Thromb Hemost 31 139-149.
3. M.P. Abbracchio, G. Burnstock, J.M. Boeynaems, E.A. Barnard, J.M. Boyer, C. Kennedy, et al. (2005) The recently deophanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor. Trend Pharmacol Sci 26 8-9.
4. L. Wang, O. Ostberg, A.K. Wihlborg, H. Brogren, S. Jern and D. Erlinge (2003) Quantifi cation of ADP and ATP receptor expression in human platelets. J Thromb Haemost 1 330-336.
5. E.M. Huang and T.C. Detwiler (1986) Stimulus-response coupling mechanisms. D.R. Phillips, M.A. Shuman (Eds) Biochemistry of platelets Orlando, FL: Academic Press. 1-68.
6. C.R. Falcon, M. Cattaneo, A. Ghidoni and P.M. Mannucci (1993) The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionised calcium. Thromb Haemost 70 389-392.
7. J.F. Mustard, D.W. Perry, R.L. Kinlough-Rathbone and M.A. Packham (1975) Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 228 1757-1765.
8. M.A. Packham and J.F. Mustard (2005) Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: A historical perspective. Semin Thromb Hemost 31 129-138.
9. M. Cattaneo, C. Gachet, J.P. Cazenave and M.A. Packham (2002) Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets. Blood 99 3868-3869.
10. M. Cattaneo and C. Gachet (1999) ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 19 2281-2285.
11. M. Cattaneo, M.T. Canciani, A. Lecchi, R.L. Kinlough-Rathbone, M.A. Packham, P.M. Mannucci and J.F. Mustard (1990) Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 75 1081-1086.
12. M. Cattaneo, B. Akkawat, R.L. Kinlough-Rathbone, M.A. Packham, C. Cimminiello and P.M. Mannucci (1994) Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin. Thromb Haemost 71 91-94.
13. C. Trumel, B. Payrastre, M. Plantavid, B. Hechler, C. Viala, P. Presek, E.A. Martinson, J.P. Cazenave, H. Chap and C. Gachet (1999) A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94 4156-4165.
14. D.C. Mills (1996) ADP receptors on platelets. Thromb Haemost 76 835-856.
15. R.W. Colman (1990) Aggregin: A platelet ADP receptor that mediates aggregation. FASEB J 3 1425-1435.
16. N.J. Greco, N.N. Yamamoto, B. Jackson, N.N. Tandon, M.J. Moos and G.A. Jamieson (1991) Identifi cation of a nucleotide binding site on glycoprotein IIb. Relationship to platelet activation. J Biol Chem 266 13627-13633.
17. N.J. Cusack and S.M.O. Hourani (1982) Adenosine diphosphate antagonists and human platelets: No evidence that aggregation and inhibition of adenylate cyclase are mediated by different receptors. Br J Pharmacol 76 221-227.
18. S.M.O. Hourani, L.A. Welford and N.J. Cusack (1996) Effects of 2-methylthioadenosine 5.í, γ-methylenetriphosphonate and 2-ethylthioadenosine 5.-monophosphate on human platelet aggregation induced by adenosine 5.-diphosphate. Drug Dev Res 38 12-23.
19. D.E. Macfarlane and D.C. Mills (1981) Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J Cyclic Nucleotide Res 7(1), 1-11.
20. D.E. MacFarlane, P.C. Srivastava and D.C. Mills (1983) 2-Methylthio-adenosine[beta32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest 71 420-428.
21. C. Léon, B. Hechler, C. Vial, C. Leray, J.P. Cazenave and C. Gachet (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403 26-30.
22. C. Leon, C. Vial, C. Gachet, P. Ohlmann, B. Hechler, J.P. Cazenave, A. Lecchi and M. Cattaneo (1999) The P2Y1 receptor is normal in a patient presenting a severe defi ciency of ADP-induced platelet aggregation. Thromb Haemost 81 775-781.
23. B. Hechler, A. Eckly, P. Ohlmann, J.P. Cazenave and C. Gachet (1998) The P2Y1 receptor, necessary but not suffi cient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 103 858-866.
24. J. Jin, J.L. Daniel and S.P. Kunapuli (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273 2030-2034.
25. P. Savi, P. Beauverger, C. Labouret, M. Delfaud, V. Salel, M. Kaghad and J.M. Herbert (1998) Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 422 291-295.
26. J.L. Daniel, C. Dangelmaier, J. Jin, B. Ashby, J.B. Smith and S.P. Kunapuli (1998) Molecular basis for ADPinduced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273 2024-2029.
27. J. Geiger, P. Honig-Liedl, P. Schanzenbacher and U. Walter (1998) Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 351 235-246.
28. Fagura M.S., Dainty I.A., McKay G.D., Kirk I.P., Humphries R.G., Robertson M.J., Dougall I.G. and Leff P., P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP) receptors. Br J Pharmacol, 124, pp. 157-164.
29. H.M. Jantzen, L. Gousset, V. Bhaskar, D. Vincent, A. Tai, E.E. Reynolds and P.B. Conley (1999) Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 81 111-117.
30. C. Gachet, M. Cattaneo, P. Ohlmann, B. Hechler, A. Lecchi, J. Chevalier, D. Cassel, P.M. Mannucci and J.P. Cazenave (1995) Purinoceptors on blood platelets: Further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 91 434-444.
31. C. Leon, B. Hechler, M. Freund, A. Eckly, C. Vial, P. Ohlmann, A. Dierich, M. LeMeur, J.P. Cazenave and C. Gachet (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104 1731-1737.
32. J.E. Fabre, M. Nguyen, A. Latour, J.A. Keifer, L.P. Audoly, T.M. Coffman and B.H. Koller (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-defi cient mice. Nat Med 5 1199-1202.
33. G. Hollopeter, H.M. Jantzen, D. Vincent, G. Li, L. England, V. Ramakrishnan, R.B. Yang, P. Nurden, A. Nurden, D. Julius and P.B. Conley (2001) Identifi cation of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409 619-693.
34. P. Savi, C. Labouret, N. Delesque, F. Guette, J. Lupker and J.M. Herbert (2001) P2Y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 283 379-383.
35. J. Jin and S.P. Kunapuli (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 95 8070-8074.
36. J.F. Mustard and M.A. Packham (1970) Factors infl uencing platelet function: Adhesion, release and aggregation. Pharmacol Rev 22 97-187.
37. D.E. MacFarlane and D.C. Mills (1975) The effects of ATP on platelets: Evidence against the central role of released ADP in platelet aggregation. Blood 46 309-320.
38. M.G. Rolf, C.A. Brearley and M.P. Mahaut-Smith (2001) Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Thromb Haemost 85 303-308.
39. M. Cattaneo, P. Marchese, K.A. Jacobson and Z. Ruggeri (2002) New insights into the role of P2X1 in platelet function. Haematologica 87 13-14. [abstract]
40. M. Cattaneo, P. Marchese, K.A. Jacobson and Z.M. Ruggeri (2003) The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear. Haematology J 4(Suppl 2), 150. [abstract]
41. C. Oury, E. Toth-Zsamboki, C. Thys, J. Tytgat, J. Vermylen and M.F. Hoylaerts (2001) The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 86 1264-1271.
42. C. Oury, E. Sticker, H. Cornelissen, R. De Vos, J. Vermylen and M.F. Hoylaerts (2004) ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem 279 26266-26273.
43. M.W. Beukers, I.M. Pirovano, A. van Weert, C.J. Kerkhof I, A.P. Jzerman and W. Soudijn (1993) Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation? Biochem Pharmacol 46 1959-1966.
44. K. Enjyoji, J. Sevigny, Y. Lin, P.S. Frenette, P.D. Christie, J.S. Esch II, M. Imai, J.M. Edelberg, H. Rayburn, M. Lech, D.L. Beeler, E. Csizmadia, D.D. Wagner, S.C. Robson and R.D. Rosenberg (1999) Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5 1010-1017.
45. A.J. Marcus, M.J. Broekman, J.H.F. Drosopoulos, K.E. Olson, N. Islam, D.J. Pinsky and R. Levi (2005) Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31 234-246.
46. S.C. Robson, Y. Wu, X. Sun, C. Knosalla, K. Dwyer and K. Eniyoji (2005) Ectonucleotidases of CD39 family modulate vascular infl ammation and thrombosis an transplantation. Semin Thromb Hemost 31 217-233.
47. C. Léon, C. Vial, J.P. Cazenave and C. Gachet (1996) Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 171 295-297.
48. C. Hoffman, S. Moro, R.A. Nicholas, T.K. Harden and K.A. Jacobson (1999) The role of aminoacids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem 274 14639-14647.
49. D. Communi, R. Janssens, N. Suarez-Huerta, B. Robaye and J.M. Boeynaems (2000) Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors. Cell Signal 12 351-360.
50. V. Ralevic and G. Burnstock (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50 413-492.
51. T.E. Webb, J. Simon, B.J. Krishek, A.N. Bateson, T.G. Smart, B.F. King, G. Burnstock and E.A. Barnard (1993) Cloning and functional expression of a brain G-proteincoupled ATP receptor. FEBS Lett 324 219-225.
52. A. Baurand, P. Raboisson, M. Freund, C. Leon, J.P. Cazenave, J.J. Bourguignon and C. Gachet (2001) Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 412 213-221.
53. J.L. Boyer, M. Adams, R.G. Ravi, K.A. Jacobson and T.K. Harden (2002) 2-Chloro N(6)-methyl-(N)-methanocarba-2.-deoxyadenosine-3.,5.-bisphosphate is a selective high affi nity P2Y(1) receptor antagonist. Br J Pharmacol 135 1839-1840.
54. G.L. Waldo, J. Corbitt, J.L. Boyer, G. Ravi, H.S. Kim, X.D. Ji, J. Lacy, K.A. Jacobson and T.K. Harden (2002) Quantitation of the P2Y(1) receptor with a high affi nity radiolabeled antagonist. Mol Pharmacol 62 1249-1257.
55. A. Baurand, A. Eckly, N. Bari, C. Leon, B. Hechler, J.P. Cazenave and C. Gachet (2000) Desensitization of the platelet aggregation response to ADP: Differential downregulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84 484-491.
56. A. Baurand, A. Eckly, B. Hechler, G. Kauffenstein, J.L. Galzi, J.P. Cazenave, C. Leon and C. Gachet (2005) Differential regulation and relocalization of the platelet P2Y receptors after activation: A way to avoid loss of hemostatic properties? Mol Pharmacol 67 721-733.
57. P. Nurden, C. Poujol, J. Winckler, R. Combrie, N. Poussea, P.B. Conley, S. Levy-Toledano, A. Habib and A.T. Nurden (2003) Immunolocalization of P2Y1 and TPalpha receptors in platelets showed a major pool associated with the membranes of alpha-granules and the open canalicular system. Blood 101 1400-1408.
58. B. Hechler, P. Toselli, C. Ravanat, C. Gachet and K. Ravid (2001) Mpl ligand increases P2Y1 receptor gene expression in megakaryocytes with no concomitant change in platelet response to ADP. Mol Pharmacol 60 1112-1120.
59. B. Hechler, C. Léon, C. Vial, P. Vigne, C. Frelin, J.P. Cazenave and C. Gachet (1998) The P2Y1 receptor is necessary for adenosine 5.-diphosphate-induced platelet aggregation. Blood 92 152-159.
60. M. Cattaneo, A. Lecchi, A.M. Randi, J.L. McGregor and P.M. Mannucci (1992) Identifi cation of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80 2787-2796.
61. M. Cattaneo (2005) The P2 receptors and congenital platelet function defects. Semin Thromb Hemost 31 168-173.
62. Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma, F. J., Jr., Wiekowski, M. T., Abbondanzo, S. J., Cook, D. N., Bayne, M. L., Lira, S. A., & Chintala, M. S. Molecular identifi cation and characterization of the platelet ADP receptor thienopyridine antithrombotic drugs. J Clin Invest, 107, 1591-1598.
63. P. Andre, T. LaRocca, S.M. Delaney, P.H. Lin, D. Vincent, U. Sinha, P.B. Conley and D.R. Phillips (2003) Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation 108 2697-2703.
64. T.M. Quinton, S. Murugappan, S. Kim, J. Jin and S.P. Kunapuli (2004) Different, G. protein-coupled signaling pathways are involved in alpha granule release from human platelets. J Thromb Haemost 2 978-984.
65. B. Hechler, Y. Zhang, A. Eckly, J.P. Cazenave, C. Gachet and K. Ravid (2003) Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice. J Thromb Haemost 1 155-163.
66. S.O. Sage, R. Reast and T.J. Rink (1990) ADP evokes biphasic Ca2+ infl ux in fura-2-loaded human platelets. Evidence for Ca2+ entry regulated by the intracellular Ca2+ store. Biochem J 265 675-680.
67. C. Soulet, B. Hechler, M.P. Gratacap, M. Plantavid, S. Offermans, C. Gachet and B. Payrastre (2005) A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation. J Thromb Haemost 3 2296-2306.
68. S. Offermans, C.F. Toombs, Y.H. Hu and M.I. Simon (1997) Defective platelet activation in Galpha (q) -defi cient mice. Nature 389 183-186.
69. P. Ohlmann, A. Eckly, M. Freund, J.P. Cazenave, S. Offermanns and C. Gachet (2000) ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq. Blood 96 2134-2139.
70. B.Z. Paul, J.L. Daniel and S.P. Kunapuli (1999) Platelet shape change is mediated by both calcium-dependent and-independent signalling pathways. Role of P160Rhoassociated coiled-coil-containing protein kinase in platelet shape change. J Biol Chem 274 28293-28300.
71. M. Bauer, M. Retzer, J.I. Wilde, P. Maschberger, M. Essler, M. Aepfelbacher, S.P. Watson and W. Siess (1999) Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets. Blood 94 1665-1672.
72. J.I. Wilde, M. Retzer, W. Siess and S.P. Watson (2000) ADP-induced platelet shape change: An investigation of the signalling pathways involved and their dependence on the method of platelet preparation. Platelets 11 286-295.
73. B. Hechler, M. Cattaneo and C. Gachet (2005) The P2 receptors in platelet function. Semin Thromb Hemos 31 150-161.
74. P. Mangin, P. Ohlmann, A. Eckly, J.P. Cazenave, F. Lanza and C. Gachet (2004) The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented. J Thromb Haemost 2 969-977.
75. K.J. Clemetson, J.M. Clemetson, A.E. Proudfoot, C.A. Power, M. Baggiolini and T.N. Wells (2000) Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96 4046-4054.
76. S. Suttitanamongkol and A.R. Gear (2001) ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC. FEBS Lett 490 84-87.
77. S. Kim, C. Foster, A. Lecchi, T.M. Quinton, D.M. Prosser, J. Jin, M. Cattaneo and S.P. Kunapuli (2002) Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 99 3629-3636.
78. P. Lova, F. Campus, R. Lombardi, M. Cattaneo, F. Sinigaglia, C. Balduini and M. Torti (2004) Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin. J Biol Chem 279 25299-25306.
79. F. Adam, T.J. Verbeuren, J.L. Fauchere, M.C. Guillin and M. Jandrot-Perrus (2003) Thrombin-induced platelet PAR4 activation: Role of glycoprotein Ib and ADP. J Thromb Haemost 1 798-804.
80. M. Cattaneo, B. Savage and Z.M. Ruggeri (2001) Effects of pharmacological inhibition of the P2Y1 and P2Y12 ADP receptors on shear-induced platelet aggregation and platelet thrombus formation on a collagen-coated surface under fl ow conditions. Blood 98 239a.
81. N.A. Turner, J.L. Moake and L.V. McIntire (2001) Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under fl ow. Blood 98 3340-3345.
82. C. Leon, M. Alex, A. Klocke, E. Morgenstern, C. Moosbauer, A. Eckly, M. Spannagl, C. Gachet and B. Engelmann (2004) Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103 594-600.
83. K. Takano, N. Asazuma, K. Satoh, Y. Yatomi and Y. Ozaki (2004) Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions. Platelets 15 223-229.
84. C. Leon, C. Ravanat, M. Freund, J.P. Cazenave and C. Gachet (2003) Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 23 1941-1947.
85. R.T. Dorsam, M. Tuluc and S.P. Kunapuli (2004) Role of protease-activated and ADP receptor subtypes in thrombin generation on human platelets. J Thromb Haemost 2 804-812.
86. P.E. van der Meijden, M.A. Feijge, P.L. Giesen, M. Huijberts, L.P. van Raak and J.W. Heemskerk (2005) Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost 93 1128-1136.
87. C. Leon, M. Freund, C. Ravanat, A. Baurand, J.P. Cazenave and C. Gachet (2001) Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: Studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 103 718-723.
88. M. Cattaneo, A. Lecchi, M. Ohno, B.V. Joshi, P. Besada, S. Tchilibon, R. Lombardi, N. Bischofberger, T.K. Harden and K.A. Jacobson (2004) Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. Biochem Pharmacol 68 1995-2002.
89. B. Hechler, C. Nonne, E.J. Roh, M. Cattaneo, J.P. Cazenave, F. Lanza, K. Jacobson and C. Gachet (2005) MRS2500, a potent, selective and stable antagonist of the P2Y1 receptor, with strong antithrombotic activity in mice. J Pharmacol Exp Ther
90. N. Lenain, M. Freund, C. Leon, J.P. Cazenave and C. Gachet (2003) Inhibition of localized thrombosis in P2Y1-defi cient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist. J Thromb Haemost 1 1144-1149.
91. N. Lenain, M. Freund, B. Hechler, C. Léon, R. Evans, J.P. Cazenave and C. Gachet (2003) The role of the P2Y1, P2Y12, and P2X1 platelet receptors in a laser induced model of arterial thrombosis in vivo. J Thromb Haemost [abstract]
92. C. Oury, T. Lenaerts, K. Peerlinck, J. Vermylen and M.F. Hoylaerts (1999) Congenital defi ciency of the phospholipase C coupled platelet P2Y1 receptor leads to a mild bleeding disorder. (Suppl) Thromb Haemost 85 20. [abstract]
93. S.L. Hetherington, R.K. Singh, D. Lodwick, J.R. Thompson, A.H. Goodall and N.J. Samani (2005) Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol 25 252-257.
94. F.L. Zhang, L. Luo, E. Gustafson, J. Lachowicz, M. Smith, X. Qiao, Y.H. Liu, G. Chen, B. Pramanik, T.M. Laz, K. Palmer, M. Bayne and F.J. Monsma.Jr (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276 8608-8615.
95. J. Takasaki, M. Kamohara, T. Saito, M. Matsumoto, S. Matsumoto, T. Ohishi, T. Soga, H. Matsushime and K. Furuichi (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: Pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 60 432-439.
96. A.K. Wihlborg, L. Wang, O.O. Braun, A. Eyjolfsson, R. Gustafsson, T. Gudbjartsson and D. Erlinge (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24 1810-1815.
97. X. Zhong, R. Kriz, J. Seehra and R. Kumar (2004) Nlinked glycosylation of platelet P2Y12 ADP receptor is essential for signal transduction but not for ligand binding or cell surface expression. FEBS Lett 562 111-117.
98. M. Cattaneo, M.L. Zighetti, R. Lombardi, C. Martinez, A. Lecchi, P.B. Conley, J. Ware and Z.M. Ruggeri (2003) Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proc Natl Acad Sci USA 100 1978-1983.
99. P. Savi, J.M. Pereillo, M.F. Uzabiaga, J. Combalbert, C. Picard, J.P. Maffrand, M. Pascal and J.M. Herbert (2000) Identifi cation and biological activity of the active metabolite of clopidogrel. Thromb Haemost 84 891-896.
100. Z. Ding, S. Kim, R.T. Dorsam, J. Jin and S.P. Kunapuli (2003) Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood 101 3908-3914.
101. G. Kauffenstein, B. Hechler, J.P. Cazenave and C. Gachet (2004) Adenine triphosphate nucleotides are antagonists at the P2Y receptor. J Thromb Haemost 2 1980-1988.
102. P. Ohlmann, K.L. Laugwitz, B. Nurnberg, K. Spicher, G. Schultz, J.P. Cazenave and C. Gachet (1995) The human platelet ADP receptor activates Gi2 proteins. Biochem J 312 775-779.
103. H.M. Jantzen, D.S. Milstone, L. Gousset, P.B. Conley and R.M. Mortensen (2001) Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest 108 477-483.
104. E.T. Bodor, G.L. Waldo, S.B. Hooks, J. Corbitt, J.L. Boyer and T.K. Harden (2003) Purifi cation and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 64 1210-1216.
105. T.M. Quinton, S. Kim, J. Jin and S.P. Kunapuli (2005) Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J Thromb Haemost 3 1036-1041.
106. R.J. Haslam (1973) Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. Ser Haematol 6 333-350.
107. P. Savi, A.M. Pfl ieger A.M. and J.M. Herbert (1996) cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coagul Fibrinolysis 7 249-252.
108. J.L. Daniel, C. Dangelmaier, J. Jin, Y.B. Kim and S.P. Kunapuli (1999) Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 82 1322-1326.
109. J. Yang, J. Wu, H. Jiang, R. Mortensen, S. Austin, D.R. Manning, D. Woulfe and L.F. Brass (2002) Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem 277 46035-46042.
110. M.P. Gratacap, J.P. Herault, C. Viala, A. Ragab, P. Savi, J.M. Herbert, H. Chap, M. Plantavid and B. Payrastre (2000) FcgammaRIIA requires a Gi-dependent pathway for an effi cient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Blood 96 3439-3446.
111. C. Dangelmaier, J. Jin, J.B. Smith and S.P. Kunapuli (2001) Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway. Thromb Haemost 85 341-348.
112. E. Hirsch, O. Bosco, P. Tropel, M. Laffargue, R. Calvez, F. Altruda, M. Wymann and G. Montrucchio (2001) Resistance to thromboembolism in PI3Kgamma-defi cient mice. FASEB J 15 2019-2021.
113. S.P. Jackson, C.L. Yap and K.E. Anderson (2004) Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 32 387-392.
114. G.E. Jarvis, R.G. Humphries, M.J. Robertson and P. Leff (2000) ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol 129 275-282.
115. G. Kauffenstein, W. Bergmeier, A. Eckly, P. Ohlmann, C. Leon, J.P. Cazenave, B. Nieswandt and C. Gachet (2001) The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin — a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 505 281-290.
116. S. Kim, J. Jin and S.P. Kunapuli (2004) Akt activation in platelets depends on Gi signaling pathways. J Biol Chem 279 4186-4195.
117. H. Shankar, S. Murugappan, S. Kim, J. Jin, Z. Ding, K. Wickman and S.P. Kunapuli (2004) Role of G proteingated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood 104 1335-1343.
118. D. Woulfe, H. Jiang, R. Mortensen, J. Yang and L.F. Brass (2002) Activation of Rap1B by G(i) family members in platelets. J Biol Chem 277 23382-23390.
119. P. Lova, S. Paganini, F. Sinigaglia, C. Balduini and M. Torti (2002) A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 277 12009-12015.
120. M.K. Larson, H. Chen, M.L. Kahn, A.M. Taylor, J.E. Fabre, R.M. Mortensen, P.B. Conley and L.V. Parise (2003) Identifi cation of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 101 1409-1415.
121. P. Lova, S. Paganini, E. Hirsch, L. Barberis, M. Wymann, F. Sinigaglia, C. Balduini and M. Torti (2003) A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. J Biol Chem 278 131-138.
122. S.P. Jackson, S.M. Schoenwaelder, I. Goncalves, W.S. Nesbitt, C.L. Yap, C.E. Wright, V. Kenche, K.E. Anderson, S.M. Dopheide, Y. Yuan, S.A. Sturgeon, H. Prabaharan, P.E. Thompson, G.D. Smith, P.R. Shepherd, N. Daniele, S. Kulkarni, B. Abbott, D. Saylik, C. Jones, L. Lu, S. Giuliano, S.C. Hughan, J.A. Angus, A.D. Robertson and H.H. Salem (2005) PI 3-kinase p110beta: A new target for antithrombotic therapy. Nat Med 11 507-514.
123. A.R. Hardy, M.L. Jones, S.J. Mundell and A.W. Poole (2004) Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 104 1745-1752.
124. S.O. Sage, E.H. Yamoah and J.W. Heemskerk (2008) The roles of P(2X1)and P(2T AC)receptors in ADP-evoked calcium signalling in human platelets. Cell Calcium 28 119-126.
125. M. Cattaneo, A. Lecchi and R. Lombardi (2003) Concomitant activation of both the P2Y1-driven Gq and the P2Y12-driven Gi pathways is necessary for normal ADP-induced mobilization of cytoplasmic Ca2+. Hematol J 4 132.
126. S.C. Fox, M.W. Behan and S. Heptinstall (2004) Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists ARC69931MX and clopidogrel is enhanced by prostaglandin E1. Cell Calcium 35 39-46.
127. R.F. Storey, H.M. Sanderson, A.E. White, J.A. May, K.E. Cameron and S. Heptinstall (2000) The central role of the P(2T) receptor in amplifi cation of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 110 925-934.
128. I.A. Jagroop, G. Burnstock and D.P. Mikhailidis (2003) Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets. Platelets 14 15-20.
129. G. Mateos-Trigos, R.J. Evans and M.F. Heath (2002) Effects of P2Y(1) and P2Y(12) receptor antagonists on ADPinduced shape change of equine platelets: Comparison with human platelets. Platelets 13 285-292.
130. M. Cattaneo, R. Lombardi, M.L. Zighetti, C. Gachet, P. Ohlmann, J.P. Cazenave and P.M. Mannucci (1997) Defi ciency of [33P]2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost 77 986-990.
131. M. Cattaneo, A. Lecchi, R. Lombardi, C. Gachet and M.L. Zighetti (2000) Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: Further evidence that some cases of platelet “primary secretion defect” are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 20 E101-E106.
132. A. Lecchi, M. Cattaneo and P.M. Mannucci (2000) ADP potentiates platelet dense granule secretion induced by U46619 or TRAP through its interaction with the P2cyc receptor. Haematologica 85(Suppl5), 83.
133. Z. Li, G. Zhang, G.C. Le Breton, X. Gao, A.B. Malik and X. Du (2003) Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases. J Biol Chem 278 30725-30731.
134. A. Eckly, J.L. Gendrault, B. Hechler, J.P. Cazenave and C. Gachet (2001) Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 85 694-701.
135. P. Andre, S.M. Delaney, T. LaRocca, D. Vincent, F. DeGuzman, M. Jurek, B.A. Koller, D.R. Phillips and P.B. Conley (2003) P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112 398-406.
136. P. Nurden, P. Savi, E. Heilmann, C. Bihour, J.M. Herbert, J.P. Maffrand and A. Nurden (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its infl uence on glycoprotein IIb-IIIa complex function. J Clin Invest 95 1612-1622.
137. R.T. Dorsam, S. Kim, J. Jin and S.P. Kunapuli (2002) Coordinated signaling through both G12/13 and G(i) pathways is suffi cient to activate GPIIb/IIIa in human platelets. J Biol Chem 277 47588-47595.
138. B. Nieswandt, V. Schulte, A. Zywietz, M.P. Gratacap and S. Offermanns (2002) Costimulation of Gi-and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. J Biol Chem 277 39493-39498.
139. N. Haseruck, W. Erl, D. Pandey, G. Tigyi, P. Ohlmann, C. Ravanat, C. Gachet and W. Siess (2004) The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: Involvement of P2Y1 and P2Y12 receptors. Blood 103 2585-2592.
140. G.W. Chacko, J.T. Brandt, K.M. Coggeshall and C.L. Anderson (1996) Phosphoinositide 3-kinase and p72syk noncovalently associate with the low affi nity Fc gamma receptor on human platelets through an immunoreceptor tyrosinebased activation motif. Reconstitution with synthetic phosphopeptides. J Biol Chem 271 10775-10781.
141. M.P. Gratacap, B. Payrastre, C. Viala, G. Mauco, M. Plantavid and H. Chap (1998) Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem 273 24314-24321.
142. J. Polgar, P. Eichler, A. Greinacher and K.J. Clemetson (1998) Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood 91 549-554.
143. A. Saci, S. Pain, F. Rendu and C. Bachelot-Loza (1999) Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120(Cbl). J Biol Chem 274 1898-1904.
144. B. Nieswandt, W. Bergmeier, A. Eckly, V. Schulte, P. Ohlmann, J.P. Cazenave, H. Zirngibl, S. Offermanns and C. Gachet (2001) Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood 97 3829-3835.
145. B.Z. Paul, J. Jin and S.P. Kunapuli (1999) Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 274 29108-29114.
146. S. Levy-Toledano, J. Maclouf, J.P. Rosa, C. Gallet, G. Valles, P. Nurden and A.T. Nurden (1998) Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on platelets. Thromb Haemost 80 463-468.
147. K. Falker, D. Lange and P. Presek (2005) P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Thromb Haemost 93 880-888.
148. K. Falker, D. Lange and P. Presek (2004) ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets. Thromb Haemost 92 114-123.
149. S. Roger, M. Pawlowski, A. Habib, M. Jandrot-Perrus, J.P. Rosa and M. Bryckaert (2004) Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett 556 227-235.
150. M. Cattaneo, R. Lombardi, D. Bettega, A. Lecchi and P.M. Mannucci (1993) Shear-induced platelet aggregation is potentiated by desmopressin (DDAVP) and inhibited by ticlopidine. Arterioscl Thromb 13 393.
151. M. Cattaneo, M.L. Zighetti, R. Lombardi and P.M. Mannucci (1994) Role of ADP in platelet aggregation at high shear: Studies in a patient with congenital defect of platelet responses to ADP. Br J Haematol 88 826-829.
152. S. Goto, N. Tamura, K. Eto, Y. Ikeda and S. Handa (2002) Functional signifi cance of adenosine 5.-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation 105 2531-2536.
153. S. Goto, N. Tamura, M. Sakakibara, Y. Ikeda and S. Handa (2001) Effects of ticlopidine on von Willebrand factormediated shear-induced platelet activation and aggregation. Platelets 12 406-414.
154. J.C. Resendiz, S. Feng, G. Ji, K.A. Francis, M.C. Berndt and M.H. Kroll (2003) Purinergic P2Y12 receptor blockade inhibits shear-induced platelet phosphatidylinositol 3-kinase activation. Mol Pharmacol 63 639-645.
155. R.F. Storey, H.M. Judge, R.G. Wilcox and S. Heptinstall (2002) Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thromb Haemost 88 488-494.
156. M. Freund, F. Mantz, P. Nicolini, C. Gachet, J. Mulvihill, L. Meyer, A. Beretz and J.P. Cazenave (1993) Experimental thrombosis on a collage coated arterioarterial shunt in rats: A pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Thromb Haemost 69 515-521.
157. S.K. Yao, J. McNatt, K. Cui, H.V. Anderson, J.P. Maffrand, L.M. Buja and J.T. Willerson (1993) Combined ADP and thromboxane A2 antagonism prevents cyclic fl ow variations in stenosed and endothelium-injured arteries in nonhuman primates. Circulation 88 2888-2893.
158. S.K. Yao, J.C. Ober, J.J. Ferguson, J.P. Maffrand, H.V. Anderson, L.M. Buja and J.T. Willerson (1994) Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis. Am J Physiol 267 H488-H493.
159. S.K. Yao, J.C. Ober, J. McNatt, C.R. Benedict, M. Rosolowsky, H.V. Anderson, K. Cui, J.P. Maffrand, W.B. Campbell, L.M. Buja, et al. (1992) ADP plays an important role in mediating platelet aggregation and cyclic fl ow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res 70 39-48.
160. J.M. Herbert, A. Bernat and J.P. Maffrand (1992) Importance of platelets in experimental venous thrombosis in the rat. Blood 80 2281-2286.
161. J.M. Herbert, A. Bernat, M. Sainte-Marie, F. Dol and M. Rinaldi (1993) Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinaseinduced thrombolysis in the rabbit. Thromb Haemost 69 268-271.
162. J.A. Remijn, Y.P. Wu, E.H.M.J.I.J. Jeninga, G. van Willigen, P.G. De Groot, J.J. Sixma, A.T. Nurden and P. Nurden (2002) Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in fl owing blood. Arterioscler Thromb Vasc Biol 22 686-691.
163. J. Huang, E.M. Driscoll, M.L. Gonzales, A.M. Park and B.R. Lucchesi (2000) Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model. J Pharmacol Exp Ther 295 492-499.
164. R.G. Humphries, W. Tomlinson, J.A. Clegg, A.H. Ingall, N.D. Kindon and P. Leff (1995) Pharmacological profi le of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. Br J Pharmacol 115 1110-1116.
165. M.A. van Gestel, J.W. Heemskerk, D.W. Slaaf, V.V. Heijnen, R.S. Reneman and M.G. Oude Egbrink (2003) Vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability Arterioscler Thromb Vasc Biol 23 518-523.
166. K. Wang, X. Zhou, Z. Zhou, K. Tarakji, M. Carneiro, M.S. Penn, D. Murray, A. Klein, R.G. Humphries, J. Turner, J.D. Thomas, E.J. Topol and A.M. Lincoff (2003) Blockade of the platelet P2Y12 receptor by AR C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model. Arterioscler Thromb Vasc Biol 23 357-362.
167. S.M. Bauer (2003) ADP receptor antagonists as antiplatelet therapeutics. Expert Opin Emerg Drugs 8 93-101.
168. C. Gachet (2005) The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Therapeut 108 180-192.
169. C. Gachet and B. Hechler (2005) The platelet P2 receptors in thrombosis. Semin Thromb Hemost 31 162-167.
170. P.B. Conley, M.M. Jurek, D. Vincent, A. Lecchi and M. Cattaneo (2001) Unique mutations in the P2Y12 locus of patients with previously described defects in ADPdependent aggregation. Blood 98 43b.
171. M. Shiraga, S. Miyata, H. Kato, H. Kashiwagi, S. Honda, Y. Kurata, Y. Tomiyama and Y. Kanakura (2005) Impaired platelet function in a patient with P2Y12 defi ciency caused by a mutation in the translation initiation codon. J Thromb Haemost 3 2315-2323.
172. M. Cattaneo (2003) Inherited platelet-based bleeding disorders. J Thromb Haemost 1 1628-1636.
173. S. Moro, C. Hoffmann and K.A. Jacobson (1998) Role of the extracellular loops of G protein-coupled receptors in ligand recognition: A molecular modeling study of the human P2Y1 receptor. Biochemistry 38 3498-3507.
174. S. Moro, D. Guo, E. Camaioni, J.L. Boyer, T.K. Harden and K.A. Jacobson (1998) Human P2Y1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 41 1456-1466.
175. U.R. Schwarz, J. Geiger, U. Walter and M. Eigenthaler (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets — defi nition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82 1145-1152.
176. P. Fontana, A. Dupont, S. Gandrille, C. Bachelot-Loza, J.L. Reny, M. Aiach and P. Gaussem (2003) Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108 989-995.
177. P. Fontana, P. Gaussem, M. Aiach, J.N. Fiessinger, J. Emmerich and J.L. Reny (2003) P2Y12 H2 haplotype is associated with peripheral arterial disease: A case-control study. Circulation 108 2971-2973.
178. N. von Beckerath, O. von Beckerath, W. Koch, M. Eichinger, A. Schomig and A. Kastrati (2005) P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphateinduced platelet aggregation after initiation of clopidogrel therapy with a high loading dose. Blood Coagul Fibrinolysis 16 199-204.
179. A.B. MacKenzie, M.P. Mahaut-Smith and S.O. Sage (1996) Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 271 2879-2881.
180. C. Vial, B. Hechler, C. Leon, J.P. Cazenave and C. Gachet (1997) Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 78 1500-1584.
181. E.E. Clifford, K. Parker, B.D. Humphreys, S.B. Kertesy and G.R. Dubyak (1998) The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 91 3172-3181.
182. T.J. Scase, M.F. Heath, J.M. Allen, S.O. Sage and R.J. Evans (1998) Identifi cation of a P2X1 purinoceptor expressed on human platelets. Biochem Biophys Res Commun 242 525-528.
183. B. Sun, J. Li, K. Okahara and J. Kambayashi (1998) P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression. J Biol Chem 273 11544-11547.
184. S. Takano, J. Kimura, I. Matsuoka and T. Ono (1999) No requirement of P2X1 purinoceptors for platelet aggregation. Eur J Pharmacol 372 305-309.
185. P. Savi, J. Bornia, V. Salel, M. Delfaud and J.M. Herbert (1997) Characterization of P2X1 purinoreceptors on rat platelets: Effect of clopidogrel. Br J Haematol 98 880-886.
186. M.P. Mahaut-Smith, S.J. Ennion, M.G. Rolf and R.J. Evans (2000) ADP is not an agonist at P2X(1) receptors: Evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 131 108-114.
187. N.J. Greco, G. Tonon, W. Chen, X. Luo, R. Dalal and G.A. Jamieson (2001) Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. Blood 98 100-107.
188. C. Vial, S.J. Pitt, J. Roberts, M.G. Rolf, M.P. Mahaut-Smith and R.J. Evans (2003) Lack of evidence for functional ADP-activated human P2X1 receptors supports a role for ATP during hemostasis and thrombosis. Blood 102 3646-3651.
189. M.G. Rolf and M.P. Mahaut-Smith (2002) Effects of enhanced P2X1 receptor Ca2+ infl ux on functional responses in human platelets. Thromb Haemost 88 495-502.
190. E. Toth-Zsamboki, C. Oury, H. Cornelissen, R. De Vos, J. Vermylen and M.F. Hoylaerts (2003) P2X1-mediated ERK2 activation amplifi es the collagen-induced platelet secretion by enhancing myosin light chain kinase activation. J Biol Chem 278 46661-46667.
191. C. Oury, E. Toth-Zsamboki, J. Vermylen and M.F. Hoylaerts (2002) P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 100 2499-2505.
192. C. Oury, M.J. Kuijpers, E. Toth-Zsamboki, A. Bonnefoy, S. Danloy, I. Vreys, M.A. Feijge, R. De Vos, J. Vermylen, J.W. Heemskerk and M.F. Hoylaerts (2003) Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 101 3969-3976.
193. B. Hechler, N. Lenain, P. Marchese, C. Vial, V. Heim, M. Freund, J.P. Cazenave, M. Cattaneo, Z.M. Ruggeri, R. Evans and C. Gachet (2003) A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 198 661-667.
194. J.A. Erhardt, K. Pillarisetti and J.R. Toomey (2003) Potentiation of platelet activation through the stimulation of P2X1 receptors. J Thromb Haemost 1 2626-2635.
195. K. Kawa (2003) Thrombopoietin enhances rapid current responses mediated by P2X1 receptors on megakaryocytic cells in culture. Jpn J Physiol 53 287-299.
196. C.Y. Fung, C.A. Brearley, R.W. Farndale and M.P. MahautSmith (2005) A major role for P2X1 receptors in the early collagen-evoked intracellular Ca2+ responses of human platelets. Thromb Haemost 94 37-40.
197. C. Vial, M.G. Rolf, M.P. Mahaut-Smith and R.J. Evans (2002) A study of P2X(1) receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 135 363-372.
198. K. Mulryan, D.P. Gitterman, C.J. Lewis, C. Vial, B.J. Leckie, A.L. Cobb, J.E. Brown, E.C. Conley, G. Buell, C.A. Pritchard and R.J. Evans (2000) Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403 86-89.
199. K. Braun, J. Rettinger, M. Ganso, M. Kassack, C. Hildebrandt, H. Ullmann, P. Nickel, G. Schmalzing and G. Lambrecht (2001) NF449: A subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn Schmiedebergs Arch Pharmacol 364 285-290.
200. M.U. Kassack, K. Braun, M. Ganso, H. Ullmann, P. Nickel, B. Boing, G. Muller and G. Lambrecht (2004) Structure-activity relationships of analogues of NF449 confi rm NF449 as the most potent and selective known P2X1 receptor antagonist. Eur J Med Chem 39 345-357.
201. B. Hechler, S. Magnenat, M.L. Zighetti, M.U. Kassack, H. Ullmann, J.P. Cazenave, R. Evans, M. Cattaneo and C. Gachet (2005) Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4.,4.,4.-(carbonylbis(imino-5,1,3-benzenet r iylbis (carbonylimino)))tetraki s-benzene-1,3-disulfonic acid octasodium salt]. J Pharmacol Exp Ther 314 232-243.
202. S. Horner, K. Menke, C. Hildebrandt, M.U. Kassack, P. Nickel, E. Ullmann, M.P. Mahaut-Smith and G. Lambrecht (2005) The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the nanomolar range. Naunyn-Schmiedebergs Arch Pharmacol 372 1-13.
203. C. Oury, E. Toth-Zsamboki, C. Van Geet, C. Thys, L. Wei, B. Nilius, et al. (2000) A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem 275 22611-22614.
204. G. Tolhurst, C. Vial, C. Leon, C. Gachet, R.J. Evans and M.P. Mahaut-Smith (2005) Interplay between P2Y, P2Y, and P2X(1) receptors in the activation of mega karyocyte cation infl ux currents by ADP: Evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling. Blood 106 1644-1651.
205. A.R. Hardy, P.B. Conley, J. Luo, J.L. Benovic, A.W. Poole and S.J. Mundell (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105 3552-3560.
206. K.A. Jacobson, L. Mamedova, B.V. Joshi, P. Besada and S. Costanzi (2005) Molecular recognition at adenine nucleotide (P2) receptors in platelets. Semin Thromb Hemost 31 205-217.
207. J.J.J. Van Giezen and R.G. Humphries (2005) Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. Semin Thromb Hemost 31 195-204.
208. Chhatriwala, M., Ravi, R. G., Patel, R. I., Boyer, J. L., Jacobson, K. A., & Harden, TK, ••. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther, 311, 1038-
209. Y. Niitsu, J.A. Jakubowski, A. Sugidachi and F. Asai (2005) Pharmacology of CS-747 (Prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. Semin Thromb Hemost 31 184-194.
210. B. Xu, A. Stephens, G. Kirschenheuter, A.F. Greslin, X. Cheng, J. Sennelo, M. Cattaneo, M.L. Zighetti, A. Chen, S.A. Kim, H.S. Kim, N. Bischofberger, G. Cook and K.A. Jacobson (2002) Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: Phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. J Med Chem 45 5694-5709.